Supernus, Inc. SEC filings INDV
Supernus, Inc. has 572 filings in SEC EDGAR's recent list, going back to Dec 2, 2014. Its latest annual report, Form ARS, was filed on Mar 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 29, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Sep 11, 2026 | — |
| S-4/A | Filing | Sep 9, 2026 | — |
| S-4 | Registration for a merger or exchange | Aug 28, 2026 | — |
| S-8 | Employee stock plan registration | Jan 26, 2026 | — |
| S-8 POS | Filing | Jan 26, 2026 | — |
| S-8 POS | Filing | Jan 26, 2026 | — |
| S-8 POS | Filing | Oct 24, 2024 | — |
| S-8 | Employee stock plan registration | Oct 24, 2024 | — |
| S-8 | Employee stock plan registration | Jun 12, 2023 | — |
| F-6 | Filing | Dec 2, 2014 | — |
Showing 10 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- INDV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Rockville, MD
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1625297
- Former names
- Indivior Pharmaceuticals, Inc. (until Nov 2, 2026); INDIVIOR PLC (until Jan 8, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.